Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Obesity Research
|
July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial
James W Anderson, Frank L Greenway, Ken Fujioka, et al.
Nutrition & Metabolism
|
August 18, 2011
Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
Harold Bays, Joy L Frestedt, Margie Bell, et al.
The Annals of Pharmacotherapy
|
August 31, 2006
Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial
James W Anderson, Susan M Schwartz, Jonathan Hauptman, et al.
Current Hypertension Reports
|
March 20, 2008
Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis
Maxwell V Rainforth, Robert H Schneider, Sanford I Nidich, et al.
Nutrition Reviews
|
April 2, 2009
Health benefits of dietary fiber
James W Anderson, Pat Baird, Richard H Davis, et al.
Journal of Contemporary Brachytherapy
|
July 24, 2013
High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes
James W Anderson, Junyi Xia, Ryan T Flynn, et al.
Diabetes Care
|
June 28, 2002
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
John M Miles, Lawrence Leiter, Priscilla Hollander, et al.
The Journal of Cell Biology
|
November 5, 2016
The ubiquitin ligase CRL2ZYG11 targets cyclin B1 for degradation in a conserved pathway that facilitates mitotic slippage
Riju S Balachandran, Cassandra S Heighington, Natalia G Starostina, et al.
Diabetes Care
|
April 30, 2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)
Sander J Robins, Hanna Bloomfield Rubins, Fred H Faas, et al.
Archives of Internal Medicine
|
December 3, 2002
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)
Hanna Bloomfield Rubins, Sander J Robins, Dorothea Collins, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Obesity Research
|
July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial
James W Anderson, Frank L Greenway, Ken Fujioka, et al.
Nutrition & Metabolism
|
August 18, 2011
Reduced viscosity Barley β-Glucan versus placebo: a randomized controlled trial of the effects on insulin sensitivity for individuals at risk for diabetes mellitus
Harold Bays, Joy L Frestedt, Margie Bell, et al.
The Annals of Pharmacotherapy
|
August 31, 2006
Low-dose orlistat effects on body weight of mildly to moderately overweight individuals: a 16 week, double-blind, placebo-controlled trial
James W Anderson, Susan M Schwartz, Jonathan Hauptman, et al.
Current Hypertension Reports
|
March 20, 2008
Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis
Maxwell V Rainforth, Robert H Schneider, Sanford I Nidich, et al.
Nutrition Reviews
|
April 2, 2009
Health benefits of dietary fiber
James W Anderson, Pat Baird, Richard H Davis, et al.
Journal of Contemporary Brachytherapy
|
July 24, 2013
High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes
James W Anderson, Junyi Xia, Ryan T Flynn, et al.
Diabetes Care
|
June 28, 2002
Effect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
John M Miles, Lawrence Leiter, Priscilla Hollander, et al.
The Journal of Cell Biology
|
November 5, 2016
The ubiquitin ligase CRL2ZYG11 targets cyclin B1 for degradation in a conserved pathway that facilitates mitotic slippage
Riju S Balachandran, Cassandra S Heighington, Natalia G Starostina, et al.
Diabetes Care
|
April 30, 2003
Insulin resistance and cardiovascular events with low HDL cholesterol: the Veterans Affairs HDL Intervention Trial (VA-HIT)
Sander J Robins, Hanna Bloomfield Rubins, Fred H Faas, et al.
Archives of Internal Medicine
|
December 3, 2002
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)
Hanna Bloomfield Rubins, Sander J Robins, Dorothea Collins, et al.
Page
of 5